SFS
AMRX icon

Sowell Financial Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Sowell Financial Services’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,566
Closed -$9K – 610
2021
Q1 		$9K Buy
+1,566
New +$8.68K ﹤0.01% 2349
2020
Q1 		– Sell
-2,600
Closed -$13K – 2405
2019
Q4 		$13K Buy
2,600
+1,500
+136% +$5.21K ﹤0.01% 1583
2019
Q3 		$3K Buy
+1,100
New +$3.84K ﹤0.01% 1899

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Sowell Financial Services's AMRX Position: Q2 2021 in Review

Sowell Financial Services sold out of Amneal Pharmaceuticals (AMRX) in Q2 2021, closing a stake of 1,566 shares — an estimated $9K sold.

Sowell Financial Services first reported a position in AMRX in Q3 2019 and held it in 3 quarters. The position peaked at $13K in Q4 2019. 160 funds tracked by Wall St. Rank hold AMRX as of Q2 2021.

  • Sowell Financial Services reported no remaining Amneal Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,566 Amneal Pharmaceuticals shares in Q2 2021, an estimated $9K.
  • Sowell Financial Services first reported a position in Amneal Pharmaceuticals in Q3 2019 and held it in 3 quarters.
  • Sowell Financial Services's Amneal Pharmaceuticals position peaked at $13K in Q4 2019.
  • 160 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.